GSKGSK
13F holders, Q1 2024 (March 31)9holders
$42.83avg. 13F price*
At the end of Q1 2024, 9 institutions reported holding GSK PLC (GSK) in their 13F filings. The largest holders were Kahn Brothers Group Inc. ($53.7M), Eagle Asset Management Inc. ($699K) and Columbia Asset Management ($309K).
- Company
- GSK PLC
- Filed as
- GLAXOSMITHKLINE PLC (Q1 2024)
- CUSIP
- 37733W105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $699K |
| Exits | 0 | $0 |
Ownership 9 holders
| Kahn Brothers Group Inc. | 7.97% | Reduce -0.5% | 1,253,644 | $53.7M |
| Eagle Asset Management Inc. | 0.00% | New | 16,467 | $699K |
| Columbia Asset Management | 0.06% | No change | 8,330 | $309K |
| Paradigm Asset Management Co. LLC | 0.02% | No change | 1,800 | $77K |
| Accent Capital Management, LLC | 0.03% | No change | 920 | $40K |
| PARK CIRCLE Co | 0.03% | No change | 800 | $34K |
| Byrne Asset Management LLC | 0.00% | No change | 56 | $2K |
| Retirement Group, LLC | 0.00% | No change | 40 | $2K |
| Huntington National Bank | 0.00% | No change | 1 | $40 |
"% of holder's portfolio" is GSK's weight in each manager's 13F, not the share of GSK PLC the manager owns.